OSSTEMIMPLANT.CO.,Ltd
KRX
✓Strengths
- Return on capital employed is moderate at 10.8%.
- Sales have compounded about 15% a year over five years.
- Has paid a dividend in each of the last 3 years on record.
!Watch-points
- Higher leverage: debt-to-equity of 2.68 is above 1.
- Thin interest cover: operating profit covers interest only about 1.2 times.
- Return on equity is on the lower side at 5.4%.
- The company reported a net loss in the latest period.
- Current ratio of 0.69 is below 1, so current liabilities exceed current assets.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreDistress zone
0.94
In Altman’s study, scores in this range were associated with a higher incidence of financial distress.
Computed without the market-value term.
Piotroski F-ScoreWeak
2 / 5
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 5 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Book Value₩ 341,918.73
ROCE10.84%
ROE5.38%
Debt to Equity2.68
Current Ratio0.69
EPS₩ 18,380.00
PAT Margin-1.06%
ICR1.21
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity